CC
CSLT

Cannell Capital’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Cannell Capital’s Portfolio CSLT Stock Details CSLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-265,543
Closed -$858K – 50
2019
Q2 		$858K Buy
+265,543
New +$915K 0.24% 45

Other funds holding CSLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Cannell Capital's CSLT Position: Q3 2019 in Review

Cannell Capital sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q3 2019, closing a stake of 265,543 shares — an estimated $858K sold.

Cannell Capital first reported a position in CSLT in Q2 2019 and held it in 1 quarter. The position peaked at $858K in Q2 2019. 99 funds tracked by Wall St. Rank hold CSLT as of Q3 2019.

  • Cannell Capital reported no remaining CASTLIGHT HEALTH, INC. position as of Q3 2019 after selling out during the quarter.
  • Cannell Capital sold 265,543 CASTLIGHT HEALTH, INC. shares in Q3 2019, an estimated $858K.
  • Cannell Capital first reported a position in CASTLIGHT HEALTH, INC. in Q2 2019 and held it in 1 quarter.
  • Cannell Capital's CASTLIGHT HEALTH, INC. position peaked at $858K in Q2 2019.
  • 99 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q3 2019.

Based on Cannell Capital's 13F filing for Q3 2019, filed 14 Nov 2019.